Human Papillomavirus and Cellular Pathways: Hits and Targets

Pathogens. 2021 Feb 25;10(3):262. doi: 10.3390/pathogens10030262.

Abstract

The Human Papillomavirus (HPV) is the causative agent of different kinds of tumors, including cervical cancers, non-melanoma skin cancers, anogenital cancers, and head and neck cancers. Despite the vaccination campaigns implemented over the last decades, we are far from eradicating HPV-driven malignancies. Moreover, the lack of targeted therapies to tackle HPV-related tumors exacerbates this problem. Biomarkers for early detection of the pathology and more tailored therapeutic approaches are needed, and a complete understanding of HPV-driven tumorigenesis is essential to reach this goal. In this review, we overview the molecular pathways implicated in HPV infection and carcinogenesis, emphasizing the potential targets for new therapeutic strategies as well as new biomarkers.

Keywords: AP-1; DNA damage response; EGFR; EMT; HPV; JAK/STAT; PI3K/Akt/mTOR; autophagy; cervical cancer; head and neck cancer; miRNA.

Publication types

  • Review